Cancer Immunotherapy intermediate
Checkpoint Inhibitor CD47
Reference for checkpoint inhibitor CD47 in peptide research.
By Encyclopeptide Editorial | 1 min read
checkpoint-inhibitor CD47 checkpoint inhibitor cancer-immunotherapy
Overview
checkpoint inhibitor CD47 is a peptide studied in cancer immunotherapy research.
Properties
| Property | Value |
|---|---|
| Parent | checkpoint-inhibitor |
| Variant | CD47 |
| Type | Checkpoint inhibitor |
| Category | Cancer Immunotherapy |
Significance
This checkpoint inhibitor has been investigated for its biological activity and therapeutic potential.
References
- Encyclopeptide Database. “checkpoint-inhibitor-CD47” monograph. encyclopeptide.com.
Chemical Identity
| Property | Value |
|---|---|
| Name | Checkpoint Inhibitor CD47 |
| Category | Cancer Immunotherapy |
Test Your Knowledge
Reinforce what you learned about Checkpoint Inhibitor CD47 with interactive quizzes on Wikipept.
Take a Quiz on Wikipept